Stock Track | Tempus AI Plunges 5.07% After-Hours as Adjusted EBITDA Misses Estimates Despite Revenue Beat
Stock Track
Feb 25
Tempus AI's stock fell 5.07% in after-hours trading on Tuesday following the release of its fourth-quarter 2025 financial results.
The AI precision medicine company reported revenue of $367.2 million for the quarter, representing 83% year-over-year growth and beating analyst expectations of $362.3 million. Adjusted loss per share of $0.04 was in line with estimates.
However, investors focused on the company's Adjusted EBITDA of $12.89 million, which fell short of the $21.37 million consensus estimate. This miss appears to have driven the post-market selloff, despite the company's strong revenue growth and 2026 revenue guidance of approximately $1.59 billion with Adjusted EBITDA projected at $65 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.